Matches in Nanopublications for { ?s ?p "[Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1249311.RAJRVi_7rsciIHAFBfp8Gv8mHqN_i2ypTzpULbVMT_Zgw130_assertion description "[Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249311.RAJRVi_7rsciIHAFBfp8Gv8mHqN_i2ypTzpULbVMT_Zgw130_provenance.
- NP1249319.RANd8SCiPQc0btS_awK1sbVbct4p7ukhfHMFwOWn6ZrDQ130_assertion description "[Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249319.RANd8SCiPQc0btS_awK1sbVbct4p7ukhfHMFwOWn6ZrDQ130_provenance.
- NP1249312.RA44fbApSrS82VB64Q9tb2ugw7FRbxAzvyHNGcN8Dzx9Q130_assertion description "[Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249312.RA44fbApSrS82VB64Q9tb2ugw7FRbxAzvyHNGcN8Dzx9Q130_provenance.
- NP1249313.RA70mihjtp3IKl6K6EPYrbNODg1g6_-iQzR0SbIhs5Slw130_assertion description "[Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249313.RA70mihjtp3IKl6K6EPYrbNODg1g6_-iQzR0SbIhs5Slw130_provenance.